Predict your next investment

Venture Capital
axiomventures.com

See what CB Insights has to offer

Investments

87

Portfolio Exits

25

About Axiom Venture Partners

Axiom Venture Partners provides capital and strategic assistance to rapidly growing high technology companies. With over $200M in capital under management, the firm seeks to consider investment proposals in two main industry areas. The first is High Technology which includes Communications, Software, Internet Infrastructure and Information Technology. Biotechnology constitutes the second area. Located in Hartford, Connecticut, Axiom invests actively throughout the United States in early or late stage companies. Approximately 15 Axiom portfolio companies have successfully completed IPO's in recent years.

Axiom Venture Partners Headquarters Location

CityPlace II - 17th Floor 185 Asylum Street

Hartford, Connecticut, 06103,

United States

(860) 548-7799

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Axiom Venture Partners Investments

87 Investments

Axiom Venture Partners has made 87 investments. Their latest investment was in Virtual Health Partners as part of their Series A - II on September 9, 2019.

CBI Logo

Axiom Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/3/2019

Series A - II

Virtual Health Partners

$0.6M

Yes

1

3/22/2019

Series A

Tangen Biosciences

$9M

Yes

2

6/27/2016

Unattributed VC

Thetis Pharmaceuticals

$4.11M

No

2

10/8/2015

Series C

Subscribe to see more

$99M

Subscribe to see more

10

7/21/2015

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/3/2019

3/22/2019

6/27/2016

10/8/2015

7/21/2015

Round

Series A - II

Series A

Unattributed VC

Series C

Series A - II

Company

Virtual Health Partners

Tangen Biosciences

Thetis Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$0.6M

$9M

$4.11M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

2

10

10

Axiom Venture Partners Portfolio Exits

25 Portfolio Exits

Axiom Venture Partners has 25 portfolio exits. Their latest portfolio exit was Payveris on August 10, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/10/2021

Acquired

$99M

2

11/6/2017

Reverse Merger

$99M

5

7/8/2011

IPO

$99M

Public

5/30/2011

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/1/2010

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/10/2021

11/6/2017

7/8/2011

5/30/2011

9/1/2010

Exit

Acquired

Reverse Merger

IPO

Acquired

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

5

10

10

Axiom Venture Partners Team

8 Team Members

Axiom Venture Partners has 8 team members, including current Founder, General Partner, Samuel F. Mckay.

Name

Work History

Title

Status

Molly Joel Coye

Founder

Current

Samuel F. Mckay

Founder, General Partner

Current

Henry Zachs

Chief Executive Officer

Current

Seth Godin

President

Current

John S. Wieczorek

Chief Financial Officer

Current

Name

Molly Joel Coye

Samuel F. Mckay

Henry Zachs

Seth Godin

John S. Wieczorek

Work History

Title

Founder

Founder, General Partner

Chief Executive Officer

President

Chief Financial Officer

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.